<p>Characteristics of the patients and healthy controls included in Study 1 and 2.</p
Clinicopathological characteristics of the patients involved in this study (n = 95).</p
Demographic and clinical characteristics of patients whose samples were used in the study.</p
<p>Characteristics at baseline and at follow-up of the patients included in the study.</p
<p>Demographic and clinical features of patients and healthy controls included in the study.</p
<p>Clinical and analytical characteristics of patients included in the study.</p
<p>Characteristics of the patients of 1) the pilot study and 2) the reliability study.</p
<p>Clinical characteristics of healthy controls and MS subjects in the MRS studies.</p
<p>Clinical characteristics of control and diabetic patients involved in the study.</p
Demographic and Clinical characteristics of the patients included in the study (N = 337).</p
<p>Clinical characteristics of the subjects enrolled in the present study (Data are mean±SD).</p
Characteristics of the major clinical subgroups and their healthy control counterparts.</p
<p>Clinical Characteristics of the patients who participated in study (n = 60).</p
<p>Characteristics of POAG patients and control subjects included in this study.</p
<p>Characteristics of the patients included or excluded from the study among the 2573 enrolled patie...
<p>Demographic and clinical characteristics of the patient groups under study.</p
Clinicopathological characteristics of the patients involved in this study (n = 95).</p
Demographic and clinical characteristics of patients whose samples were used in the study.</p
<p>Characteristics at baseline and at follow-up of the patients included in the study.</p
<p>Demographic and clinical features of patients and healthy controls included in the study.</p
<p>Clinical and analytical characteristics of patients included in the study.</p
<p>Characteristics of the patients of 1) the pilot study and 2) the reliability study.</p
<p>Clinical characteristics of healthy controls and MS subjects in the MRS studies.</p
<p>Clinical characteristics of control and diabetic patients involved in the study.</p
Demographic and Clinical characteristics of the patients included in the study (N = 337).</p
<p>Clinical characteristics of the subjects enrolled in the present study (Data are mean±SD).</p
Characteristics of the major clinical subgroups and their healthy control counterparts.</p
<p>Clinical Characteristics of the patients who participated in study (n = 60).</p
<p>Characteristics of POAG patients and control subjects included in this study.</p
<p>Characteristics of the patients included or excluded from the study among the 2573 enrolled patie...
<p>Demographic and clinical characteristics of the patient groups under study.</p
Clinicopathological characteristics of the patients involved in this study (n = 95).</p
Demographic and clinical characteristics of patients whose samples were used in the study.</p
<p>Characteristics at baseline and at follow-up of the patients included in the study.</p